chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My husband was diagnosed with COVID-19 I would say 5 days prior around 01/05. He had a positive home test and we immediately occupied different rooms of our home. Five days went by and I had thought I wasn't going to get it. Then I had an onset of fatigue, achiness, headache, and chills on 01/08/2023. I tested that right away and I was positive. I knew to call for a prescription for Paxlovid. I called early the next morning and left a message. I got a response late that same afternoon on 01/09/2023. The prescription had been called in for me and I talked to my PCP. I started that medication that very day on 01/09. I started the Paxlovid within 24-48 hours after my first symptoms. I took that for the prescribed 5 days. My symptoms were dramatically improved the next morning. I felt 80% better. I did my isolation for 5 days, and I felt very good. I started going for walks outside after a few days. I never got anything else. I had no respiratory symptoms. It was over within just a few days.
had a shingles shot and still got a mild case, Suspected vaccination failure; had a shingles shot and still got a mild case.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient had a shingles shot and still got a mild case of shingles. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were not provided.
Very hot and uncomfortable ear for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of EAR DISCOMFORT (Very hot and uncomfortable ear for 24 hours) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EAR DISCOMFORT (Very hot and uncomfortable ear for 24 hours). At the time of the report, EAR DISCOMFORT (Very hot and uncomfortable ear for 24 hours) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
pt recvd DTP/HIB/OPV on 18FEB92; on 21FEB parents reported that rt lower leg & foot were swollen; HIBTITER was given in the rt leg; no induration @ inject site; swelling confirmed @ office visit; pt fine otherwise;
Fever; Chills; She felt tired; Face was swollen around jawline on left side; Left arm was very sore and throbbing at injection site; Pain in both shoulders/pain in back of right knee; Lip tingled; Throat opened like she was going to throw up; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Lip tingled), PAIN IN EXTREMITY (Left arm was very sore and throbbing at injection site), SWELLING FACE (Face was swollen around jawline on left side), VOMITING (Throat opened like she was going to throw up) and ARTHRALGIA (Pain in both shoulders/pain in back of right knee) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PARAESTHESIA ORAL (Lip tingled) and VOMITING (Throat opened like she was going to throw up). On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Left arm was very sore and throbbing at injection site) and ARTHRALGIA (Pain in both shoulders/pain in back of right knee). On 20-Jan-2021, the patient experienced SWELLING FACE (Face was swollen around jawline on left side). On 22-Jan-2021, the patient experienced FATIGUE (She felt tired). On 27-Jan-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PARAESTHESIA ORAL (Lip tingled), PAIN IN EXTREMITY (Left arm was very sore and throbbing at injection site), SWELLING FACE (Face was swollen around jawline on left side), VOMITING (Throat opened like she was going to throw up), ARTHRALGIA (Pain in both shoulders/pain in back of right knee), FATIGUE (She felt tired), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment:Tylenol   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: contact info updated On 05-Apr-2021: Source Document attached
administer expired vaccine to patients, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.) in an 82-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration.) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. It was reported that vials had not undergone any temperature excursion.  Total of 173 doses were given from LOT 070H21A.  No treatment medication were reported   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received includes non-significant information.
swelling from shoulder to tip of elbow;erythema extedning 24x25cm (almost lapping circumference of arm);intensely itchy & painful;nausea & h/a;tx w/atarax;
Patient described to prescriber-itching, redness and bumps.  Prescriber on 6-6-16 described as bright red, warm with small papules and diagnosis of cellulitis of upper limb.
Local reaction at injection site, 9 days after injection. Redness, swelling, and warmth.
I began to have a massive headache. It hurt on the top of my head and on my forehead.  I also began to feel chills and body aches. I felt like I had the flu. I took Tylenol or Advil and it lasted about 3 or 4 hours. I had a hard time falling asleep from the pain. For the next two days I still had the same symptoms off and on.
Pt's left arm had red, warm spot size of a 50 cent piece at area where IPV given, this happened on the 2nd day after imms given. Mother took child to doctor where he was prescribed Keflex.
This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received 4 to 5 years ago). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown. Additional details were provided are as follows: The age at vaccination was not applicable for this report. Nurse practitioner reported that till time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter remained anonymous and no other adverse event information was provided. The reporter did not gave consent for safety team to follow-up.
Genralized urticarial react w/in 8 hrs of inject that proceeded to blisters in webs of fingers, dermatines of arms & behind the ear bilaterally; lasted 24-36 hrs;
This spontaneous report was received from a healthcare worker and refers to multiple unspecified patients of unknown ages and genders. The patients' concurrent conditions and medical history were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB injection, lot # L039660, expiry date 04-FEB-2018 (dose and route were not reported). Concomitant therapies were not provided. According to the reporter, the vaccines were stored at temperatures from 46.9 to 55.8 degrees Fahrenheit, for 24 hours. There was no previous temperature excursion reported. No adverse effect was reported. No product quality complain (PQC) was involved. Additional information has been requested.
Day 8 after vaccine patient developed itching, welt and rash at injection site.  She was in terrible pain.  She used Allegra and Benadryl, applied cold compress and topical hydrocortisone cream.  Had some relief, however on Day 15 after vaccine started to feel itching in armpit and on her back.  She called the doctor and on day 18 was given a steroid injection and oral steroids for 3 days.  This seemed to clear up her rash, however a few days after finishing steroids she developed rash over entire torso.  Called allergist and on 3/11/21 placed back on steroids orally and topically.  Taking Allegra in the morning and Zyrtec in the evenings.  Per her allergist advised not to get second vaccine.  Allergist plans to do skin test to check for allergies to vaccine ingredients.
Severe left knee pain at onset 10 days after J+J vaccine; better since onset; affecting daily activities. associated signs and symptoms: edema; warmth; stiffness; limitation of movement; weakness; instability; limp; fatigue.
they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.; adult patient received Moderna COVID-19 vaccine after 30 day BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD) and PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     The patient had no known drug allergy (KNDA). It was unknown whether the patient was never diagnosed/tested positive for COVID-19.  It was unknown whether the patient had any acute illness at the time of vaccination and up to one month before it.  Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE on 15-May-2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE. Concurrent medical conditions included Hypertension, Hypercholesterolaemia and Diabetes. Concomitant products included LEVOTHYROXINE, WARFARIN, SIMVASTATIN and METOPROLOL for an unknown indication.    On 09-Jul-2022 at 9:56 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milligram. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD) and PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (adult patient received Moderna COVID-19 vaccine after 30 day BUD) and PRODUCT STORAGE ERROR (they received the Moderna on 08Jun2022 refrigerated with 30 day use by date of 08Jul2022.) to be not related.    The vial was initially stored in the refrigerator on 08-Jun-2022. The best use by date was 08-Jul-2022. The patient had inadvertently given one day past the 30-day refrigeration date. The patient had no adverse reaction.  The patient did not seek medical care in response to the event.  The patient did not experience similar event in the past.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2022: Follow up received include significant information removed classification of invalid, reporter details, patient initials, age, ethnic, race, added historical vaccine and suspect vaccine details, added concomitant medications, updated reporter causality from not provided to not related and narrative updated.
Symptoms began approx. 2 weeks after vaccine. Parsonage-Turner Plexopathy syndrome including: heaviness, weakness, & neuropathic pain in left limb with tingling in fingers.
Initial report received from a healthcare professional on 22 AUGUST 2013. An 11-year-old female patient whose medical history and concomitant medications were not reported, had received a dose of ADACEL (batch number, dose in series, route and site of administration was not reported) on an unspecified date. On an unspecified date, the patient developed unspecified local side effects that were worse than usual. Laboratory investigations and the corrective treatments were not reported. The outcome of the event was not reported. Documents held by sender: none.
Patient received the 2nd dose of the Moderna Covid 19 Vaccination on 3/09/21 in her left deltoid muscle. The patient reports that after her 1st dose of the vaccine she had some adverse reaction that included some facial swelling, that resolved with a single dose of Benadryl. She denied any other symptoms. Due to the patient report, she was monitored post receiving the 2nd dose of the same vaccine. Patient reported upper lip swelling at 10:30 am. Patient was given Benadryl 50 mg po at 10:37 am. Vitals remained stable and 02 was at 100%. Patient was released home following her observation.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Mar2021 as dose 1, single (Lot number: EN6206), in left arm, on 29Mar2021 as dose 2, single (Lot number: ER8732), in left arm, on 09Dec2021 as dose 3 (booster), single (Lot number: FE3584), in left arm and on 26Apr2022 as dose 4 (booster), single (Lot number: FM7553) at the age of 66 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "obesity" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "herniated discs" (unspecified if ongoing); "history of pericarditis" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ALLER ZYR; MELOXICAM; LOSARTAN HCTZ; LEVOTHYROXINE SODIUM; GABAPENTIN. Past drug history included: Levaquin, reaction(s): "Known allergies: Levaquin"; Avelox, reaction(s): "Known allergies: Avelox". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "Treatment of COVID-19". After taking the antiviral (COVID 19 Treatment; brand: Pfizer), patient improved and tested negative the morning of 02Nov2022. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (02Nov2022) negative, notes: tested negative the morning of 02Nov2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Pt with history of COVID illness (January 2021) and fully vaccinated now inpatient with positive COVID PCR test
Immediately dizzy, vomiting, blood pressure went up.  Still to this day I have Vertigo
pt reports pain to R. Deltoid traveling to RFA. pain present both resting and with ROM
p/vax pt has very sore arm; muscle pains in back; hip & shoulders; general aches & pins throughout body
ACUTE MASSIVE PULMONARY EMBOLISM, ACUTE DEEP VEIN THROMBOSIS, MULTPLE SUBSEGMENTAL PULMONARY EMBOLI
Information has been received form an unknown reporter referring to unknown number of patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medication were not reported. On unknown dates, unknown number of patients were probably vaccinated with improperly stored doses of VAQTA (lot# and expiration date not specified; dose, route, site of administration unknown) for prophylaxis. It was reported that VAQTA lot # K005958 (reported expiration date 09-FEB-2017, but auto generated expiration date 09-FEB-2016), lot # K018182 (expiration date 12-FEB-2017), lot # K019560 (expiration date 02-JUN-2017), lot # reported as WK747 (expiration date 21-AUG-2017) and lot # L039659 (expiration date 15-MAR-2017) underwent a temperature excursion in 2015. From May 2015 to December 2015, the minimal/maximal temperature was 33/46, 32/46, 32/ 47, 31/48, 32/47, 32/48, 32/48 and 31/56 (units not provided) respectively. The lot number L039659 (expiration date 15-MAR-2017), L023936 (expiration date 15-MAR-2017), M018644 (expiration date not reported but auto generated as 20-SEP-2017), M022924 (expiration date 24-JAN-2018), M027879 (expiration date 24-JAN-2018) underwent a temperature excursion in 2016. In January to September, November and December of 2016, the minimal/maximal temperature was 31/49, 31/49, 30/ 86, 31/75, 30/49, 27/86, 29/86, 26/51, 28/54, 24/49 and 24/53 (units not provided) respectively. There was no VAQTA lot number reported in 2017 temperature excursions.  This is one of several reports received from the same source. Additional information has been requested. ; Sender's Comments:  US-009507513-1705USA007740: US-009507513-1705USA007741: US-009507513-1705USA004287: Original Case : 1705USA004287 US-009507513-1706USA001292: US-009507513-1706USA001290: US-009507513-1706USA001289: US-009507513-1706USA001288: US-009507513-1706USA001291:
Information has been received from a registered nurse concerning a female patient who on 19MAR2001 was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). ON 19DEC2002 the patient received a second dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). It was reported that a titer was drawn after each dose and the pt failed to seroconvert each time. Unspecified medical attention was sought. Additional information has been requested.
10-15 minutes after injection felt lightheaded/loopy--similar to 1st dose. vitals stable water given observed in car for an additional 20-30 minutes
employee reports hives left upper arm started on 3/25/20 at 09:00 and numbness to fingertips next day numbness progress to whole arm including upper shoulder blade.  Employee went to her PCP and was prescribed prednisone 10mg.  In the evening of 3/25/20, employee reports left leg numbness and left neck area numb as well.  Employee reports that her husband notice change in behavior and speech.  This resolved in 45 minutes and refused to go to ED.  On 3/26/20 numbness presented to left check, jaw, left eye, and left side of tongue.  At this time, Employee decided to ED.
FLu like symptoms. large localized reaction at injection site. Ibuprofen/Tylenol, warm compresses.
The next day in the morning my moles and scars were burning like on fire especially at 5pm. Some days it burns and some days no symptoms. I got very sick the next 3 days, cold, achy, and tire but no fever.
COVID arm; itching; redness; swelling in arm; larger rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), PRURITUS (itching), ERYTHEMA (redness), PERIPHERAL SWELLING (swelling in arm) and RASH (larger rash on arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), PRURITUS (itching), ERYTHEMA (redness), PERIPHERAL SWELLING (swelling in arm) and RASH (larger rash on arm). At the time of the report, VACCINATION SITE REACTION (COVID arm) had resolved and PRURITUS (itching), ERYTHEMA (redness), PERIPHERAL SWELLING (swelling in arm) and RASH (larger rash on arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment included topical steroid NOS.
Patient reported chest pain and tightness the same day that he received the vaccine.   I asked if he had experienced this before and he said yes but it had been a while since he experienced it.  I instructed him to seek medical care if symptoms persist.  Patient called back over weekend and stated that he had been hospitalized over the weekend and was then discharged.  He was diagnosed with myocarditis.
Pt fainted and hit her head when she fainted. I did not notice any seizure activity.
Pt was given Pfizer Dose 1 nearly 2 months after receiving Moderna dose 1. Pt completing screening questionnaire which nurse reviewed Prior to immunization. Pt did not indicate that he had received a vaccine previously.  when nurse went to document vaccine they noted that pt had previously received Modern vaccine.. Pt was instructed to not get any further vaccinations for Covid-19. Pt has mental health issues which may or may have not contributed to this event.
body ache; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), CHILLS (chills) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (body ache), CHILLS (chills) and HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (body ache), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.